Bone Marrow TransplantationSpeech-Language PathologyBone MarrowTreatment OutcomeTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesRetrospective StudiesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHIV InfectionsRecurrenceHematopoiesisCombined Modality TherapyMice, Inbred C57BLTime FactorsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseImmunosuppressionStem Cell TransplantationLymphocyte DepletionLymphoma, Non-HodgkinHeart TransplantationSurvival AnalysisLeukocyte TransfusionSevere Combined ImmunodeficiencyFollow-Up StudiesT-LymphocytesChimeraColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineBone DensityHematologic DiseasesSurvival RateLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationPrognosisPancytopeniaGraft vs Tumor EffectCell DifferentiationCytarabineLeukocyte CountGraft vs Leukemia EffectCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CEtoposideDisease-Free SurvivalFlow CytometryMultiple MyelomaFatal OutcomeLymphomaProspective StudiesCells, CulturedHodgkin DiseasePostoperative ComplicationsAntigens, CD34Infection